Usana Health Sciences (USNA) Invested Capital (2014 - 2026)

Usana Health Sciences (USNA) has 7 years of Invested Capital data on file, last reported at $14.0 million in Q2 2026.

• On a quarterly basis, Invested Capital fell 39.13% year-over-year to $14.0 million in Q2 2026; TTM through Apr 2026 was $28.0 million, a 39.13% decrease from a year earlier, with the FY2026 full-year figure at $14.0 million, down 39.13% from the prior year.
• Invested Capital for Q2 2026 stood at $14.0 million, roughly flat from $14.0 million in the prior quarter.
• Over the last five years, Invested Capital for USNA reached as high as $23.0 million in Q4 2024 and fell as low as $786000.0 in Q4 2023.
• Historically, Invested Capital has averaged $12.3 million across 5 years, with a median of $14.0 million in 2026.
• Across the five-year window, Invested Capital surged 2826.21% in 2024 and slumped 39.13% in 2026, its largest moves.
• Year by year, Invested Capital stood at $10.0 million in 2022, then sank by 92.14% to $786000.0 in 2023, then surged by 2826.21% to $23.0 million in 2024, then changed by 0.0% to $23.0 million in 2025, then sank by 39.13% to $14.0 million in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $14.0 million in Q2 2026, $14.0 million in Q1 2026, and $23.0 million in Q1 2025.